Total raised
$6.5M
Last: Seed 2025-07
Stage
Seed
Founded
2025
Headcount
5
HQ
Givat Brenner
Sector
Health Tech & Life Sciences
About
LeaFix developed the only Transcatheter Functional Mitral valve Regurgitation repair solution, performed by an augmentation of the anterior leaflet. The system is composed of an implant and a delivery system, used for implantation of an implant into the anterior leaflet while expanding the implant within the leaflet, hence enlarging the leaflet area and creating coaptation of the leaflets.
Funding history · 1 round · $6.5M total
2025-07
Seed
$5.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Tags
cardiovascularcatheterscardiology